The company develops clinically tested digital medicines and therapeutics for chronic and specialty conditions, including rare diseases, with solutions adapted to address the needs of special populations and vulnerable communities internationally. Its scientifically tested and scalable solutions include TAVIE, a personalized patient support and digital medicine, Persist-Rx, a digital therapeutics solution for optimizing treatment for chronic pain, TrialAdvisor for clinical trials performance, and Clinikly for healthcare ecosystem management, data/analytics, population health, and RWE. The company's products and services are successfully deployed globally, serving a wide range of clients, including pharmaceuticals/biotech, government, and insurance clients, in conditions such as cancer, psoriasis, HIV, and chronic pain.